In a major development in Indian healthcare sector, the Government of India and the major pharmaceutical industry companies have collectively come forward to build a nation that has responsible Healthcare Trust to support the Brand India Pharma campaign. A unique public-private collaboration, thecreation of the Trust showcases the dedication to secure the motives and goals of the pharma sector.
The Trust chaired by the Commerce Secretary comprises key stakeholders, namely, the IndianPharmaceutical Alliance (IPA), Indian Drug Manufacturers Association (IDMA), Bulk Drug Manufacturers Association (BDMA), Association of Biotechnology Led Enterprises (ABLE), Pharmaceutical Export Promotion Council of India (Pharmexcil) and India Brand Equity Foundation (IBEF). The Trust aims to combine both financial and non-financial resources towards a common agenda.
The Trust aims to create better awareness and develop an informed perspective about BrandIndia Pharma in both the domestic and global markets.
The India Responsible Healthcare Trust will spearhead the Brand India Pharma initiativethrough the second phase. The industry-government partnership is an important milestone in the campaign, said Mr Rajeev Kher, Commerce Secretary, Government of India.
The Brand India Pharma campaign was launched under the aegis of the Department of Commerceat CPhI Japan in March 2012. The Brand India Pharma showcase has made its presence feltat prestigious events like CPhI Worldwide consistently over the past two years. The Department of Commerce along with IBEF and Pharmexcil has invested huge resources with measurable and impacting results in the first phase of the Brand India Pharma
The India Responsible Healthcare Trust is planned to carry forward the Brand India Pharmacampaign to a much higher level. And the main objective of this Trust will be to give India an image ofa Responsible Healthcare provider.